APDN:NSD-Applied DNA Sciences Inc (USD)

COMMON STOCK | Diagnostics & Research | NSD

Last Closing Price

USD 5.17

Change

+0.10 (+1.97)%

Market Cap

USD 0.04B

Volume

0.13M

Avg Analyst Target

USD 11.00 (+112.77%)

Avg User Target

USD
Average Analyst Rating

Verdict

Fundamental Analysis

Verdict


Applied DNA Sciences Inc (APDN) Stock Analysis:
Based on the Applied DNA Sciences Inc stock forecasts from 1 analysts, the average analyst target price for Applied DNA Sciences Inc is USD 11.00 over the next 12 months. Applied DNA Sciences Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Applied DNA Sciences Inc is Bearish, which is based on 1 positive signals and 3 negative signals. At the last closing, Applied DNA Sciences Inc’s stock price was USD 5.17. Applied DNA Sciences Inc’s stock price has changed by -0.61 % over the past week, -0.58 % over the past month and -23.97 % over the last year.

About

Applied DNA Sciences, Inc. develops and markets DNA-based technology solutions for use in the nucleic acid-based in vitro diagnostics and preclinical nucleic-acid based drug development and manufacturing markets; and for supply chain security, anti-counterfeiting, and anti-theft ...Read More

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2021-12-07 )

Largest Industry Peers for Diagnostics & Research

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
ILMN Illumina Inc

+17.78 (+5.06%)

USD54.28B 57.56 40.46
IDXX IDEXX Laboratories Inc

+19.22 (+3.25%)

USD49.73B 67.93 49.57
ICLR ICON Public Limited Company

+12.65 (+4.76%)

USD22.21B 90.49 49.93
EXAS Exact Sciences Corporation

+2.52 (+3.12%)

USD13.20B N/A N/A
PRAH PRA Health Sciences, Inc

N/A

USD10.70B 50.52 25.79
SYNH Syneos Health Inc

+3.36 (+3.40%)

USD10.37B 40.84 22.52
GH Guardant Health Inc

+6.68 (+7.53%)

USD9.22B N/A N/A
NTRA Natera Inc

+6.30 (+7.30%)

USD8.19B N/A N/A
MEDP Medpace Holdings Inc

+8.70 (+4.24%)

USD7.41B 42.44 32.46
QDEL Quidel Corporation

+3.51 (+2.51%)

USD6.17B 6.77 4.78

ETFs Containing APDN

Symbol Name Weight Mer Price(Change) Market Cap

N/A

Market Performance

  Market Performance vs.
Industry/Classification (Diagnostics & Research)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 1.37% 71% C- 49% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 1.37% 70% C- 46% F
Trailing 12 Months  
Capital Gain -23.97% 51% F 24% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -23.97% 51% F 24% F
Trailing 5 Years  
Capital Gain 140.47% 57% F 78% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 140.47% 57% F 77% C+
Average Annual (5 Year Horizon)  
Capital Gain 363.25% 98% A+ 98% A+
Dividend Return N/A N/A N/A N/A N/A
Total Return 363.25% 98% A+ 98% A+
Risk Return Profile  
Volatility (Standard Deviation) 862.30% 4% F 2% F
Risk Adjusted Return 42.13% 56% F 59% F
Market Capitalization 0.04B 9% F 10% F
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 87%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Diagnostics & Research)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio N/A N/A N/A N/A N/A
Price/Book Ratio 2.51 67% D+ 47% F
Price / Cash Flow Ratio N/A N/A N/A N/A N/A
EV/EBITDA N/A N/A N/A N/A N/A
Management Effectiveness  
Return on Equity -114.08% 15% F 17% F
Return on Invested Capital -289.32% 4% F 2% F
Return on Assets -50.98% 7% F 4% F
Debt to Equity Ratio 9.05% 80% B- 72% C-
Technical Ratios  
Short Ratio 0.63 98% A+ 82% B-
Short Percent 8.11% 23% F 20% F
Beta 1.00 57% F 57% F
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date

No discussions yet

User / Independent Analyst Ratings

User Name Target Rating Target Horizon (Months) Target Price User Analysis Date Comment

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low debt

The company is less leveraged than its peers ,, and is among the top quartile, which makes it more flexible. However, do check the news and look at its sector. Sometimes this is low because the company is not growing and has no growth potential.

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector